Trial intelligence / Profile preview

Proof-of-concept study of SB-751689 in distal radius fractures

2007-001477-29Phase 2Terminated

Sponsor
GSK
Start
May 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in distal forearm fracture comparing SB-751689 with Placebo (2 arms). Primary endpoints: Time to radiographic fracture healing and Safety and tolerability of SB-751689 over 12 weeks. Started May 2007; status: terminated.

02

Drugs

ronacaleret
03

Conditions

distal forearm fracture

Beyond the preview

Go deeper on 2007-001477-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001477-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call